Cme Group Inc. (CME)
NasdaqGS · Price as of · Nasdaq Real Time Price
- Analysts15
- Implied upside-1.0%
- Target range$230.00 to $330.00
- EPS expected$2.94 +9.7%
- A year ago$2.68
- Revenue expected$1.70B +10%
- Estimate range$2.81 to $3.15
Congress trades
| Date | Member | Action | Amount | |
|---|---|---|---|---|
| 2026-06-16 | Gil Cisneros CA | Sale | $1,001 - $15,000 |
SEC filings
| Form | Filed | Description |
|---|---|---|
| 8-K | August 11, 2026 | 8-K |
| 10-Q | July 24, 2026 | 10-Q |
| 8-K | July 22, 2026 | 8-K |
| 4 | June 29, 2026 | FORM 4 |
| 4 | June 29, 2026 | FORM 4 |
| 4 | June 29, 2026 | FORM 4 |
| 4 | June 29, 2026 | FORM 4 |
| 4 | June 29, 2026 | FORM 4 |
Frequently asked questions
When does CME report earnings?
Cme Group Inc. (CME) is scheduled to report quarterly results on October 21, 2026 (estimated). The 13-analyst consensus is $2.94 per share on revenue of $1.70B for the quarter ending September 30, 2026, against $2.68 and $1.54B a year earlier. It has beaten the consensus EPS estimate in 3 of the last four quarters. The date is an estimate from past reporting patterns and can move until the company confirms it.
What do analysts expect for CME?
15 analysts cover Cme Group Inc. (CME). The consensus rating is Hold. The average price target is $283.07, in a range of $230.00 to $330.00.
Are insiders buying or selling CME?
We have no qualifying Form 4 insider purchases or sales on record for Cme Group Inc. (CME). Sales are only tracked above a dollar threshold, so small routine trades may not appear.
Where can I see CME SEC filings?
Recent filings are listed on this page, newest first. The latest is an 8-K filed August 11, 2026.